AXA SA - NV26 (CSNV.PA) Forecast, Price Target & Analyst Ratings

EPA:CSNVFR0014013Q98

Current stock price

35.525 EUR
-3.08 (-7.97%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AXA SA - NV26 (CSNV.PA).

Forecast Snapshot

Consensus Price Target

Price Target
N/A
N/A

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q2 / 2024
EPS Estimate
€1.80
Revenue Estimate
54.142B

ChartMill Buy Consensus

Rating
84.14%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
N/A
Upside
N/A
From current price of €35.53 to mean target of N/A, Based on 29 analyst forecasts
Low
N/A
Median
N/A
High
N/A

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

Analyst Ratings & History

Current Analyst Ratings

CSNV Current Analyst RatingCSNV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10

Analyst Ratings History

CSNV Historical Analyst RatingsCSNV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
84.14%
CSNV.PA was analyzed by 29 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CSNV.PA.
In the previous month the buy percentage consensus was at a similar level.
CSNV.PA was analyzed by 29 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q2 / 2024
EPS Estimate
€1.80
Revenue Estimate
54.142B
Revenue Q2Q
32.57%
EPS Q2Q
0.70%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
CSNV.PA revenue by date.CSNV.PA revenue by date.
122.307B
7.79%
105.176B
-14.01%
85.109B
-19.08%
95.541B
12.26%
99.749B
4.40%
100.258B
0.51%
N/AN/A
EBITDA
YoY % growth
CSNV.PA ebitda by date.CSNV.PA ebitda by date.
10.779B
37.28%
N/A
-12.21%
N/A
6.34%
10.483B
4.17%
11.056B
5.47%
11.731B
6.11%
N/AN/A
EBIT
YoY % growth
CSNV.PA ebit by date.CSNV.PA ebit by date.
9.909B
48.43%
10.933B
10.33%
9.491B
-13.19%
9.472B
-0.20%
10.005B
5.63%
10.428B
4.23%
12.226B
17.24%
12.302B
0.62%
Operating Margin
CSNV.PA operating margin by date.CSNV.PA operating margin by date.
8.10%10.39%11.15%9.91%10.03%10.40%N/AN/A
EPS
YoY % growth
CSNV.PA eps by date.CSNV.PA eps by date.
2.75
60.82%
3.08
12.00%
N/A
10.30%
3.62
6.50%
3.93
8.63%
4.53
15.27%
4.53
-0.03%
4.67
3.16%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 24
EPS
Q2Q % growth
1.80
0.70%
Revenue
Q2Q % growth
54.142B
32.57%
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
N/A

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CSNV.PA Yearly Revenue VS EstimatesCSNV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20B 40B 60B 80B 100B
CSNV.PA Yearly EPS VS EstimatesCSNV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

AXA SA - NV26 / CSNV.PA Forecast FAQ

What are the consensus estimates for CSNV stock next earnings?

The consensus EPS estimate for the next earnings of AXA SA - NV26 (CSNV.PA) is 1.8 EUR and the consensus revenue estimate is 54.14B EUR.